chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Although I felt nothing during the first dose, I DID feel a prick for my second dose. It was followed by a little itch, but nothing unusual. I made sure to rub my arm and keep it moving until I went to bed a couple of hours later.  The next day, I woke up with no issues, just a slight tenderness at the injection site that only really hurt if I touched it. At about 9:30 am, almost 12 hours after the second dose, I became a bit tired, had a little chill, and was a tiny bit achy. I took two Tylenol, and continued to hydrate. I could feel myself getting more uncomfortable as the day went on. By 3:00 pm, I was freezing, could not get warm, and running a fever of 100. I took more Tylenol, and got bundled up and took a nap. At 4:00 pm, I woke up and was even colder, and had a fever of 102.4. At this point, I got into bed and had continued to hydrate and take ibuprofen (I had run out of Tylenol) every four hours. The fever broke at some point in the night, as I woke up and was soaking wet, but by the time I woke up the fever had returned and was 101. I took more Ibuprofen and the fever dropped back to normal around noon on February 18. By far, the worst feeling, aside from the fever, was the extremely severe joint pain I had in my ankles, knees, hips, arms, and hands. It was painful to stand and to walk. By Friday, I felt better, but was weak. I felt back to 100% on Saturday morning.
Typical arm swelling, pain. Then muscles ache with spasms then big toe pain. Then drooling left lip with continuous eye twitching. Massive headaches with dizziness. Full body tingling on and off.
Patient was given Flulaval quadravalent in left arm. Lot number T3959, Exp 6/2014. Within minutes of receiving the vaccine the vaccine patient became very red, she said she was hot and dizzy.  I had patient sit down and gave her a sip of water.  She complained of her throat tightening and held her hands to her throat.  I administered Epipen 0.3mg IM and called 911.  Patient began feeling better, was responsive and talking throughout.  Ambulance arrived and patient was taken to ER as a precatution.
Patient came into the clinic with a large induration around the right deltoid and a itchy rash the extended to the elbow after the 2nd Anthrax shot.  The patient was directed by the doctor to take Tylenol or Motrin prior to next Anthrax immunizations and to take Benadryl after the vaccination.
Soreness to (L) upper arm, followed by redness & warmth at injection site.
Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. In April 2021, the patient experienced MYALGIA (Muscle pain). At the time of the report, MYALGIA (Muscle pain) outcome was unknown.            Concomitant Drugs Not Reported.  The reporter's causality for the event of severe muscle pain with Humira(adalimumab) was no reasonable possibility.  Treatment Drugs Not Reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-624189 (Patient Link).
SMALL BUMPS/RASH WITH WHITE HEADS OVER BODY THAT BEGAN ON CHEST AND GROIN APPROX 6 HRS AFTER; PROGRESSED TO ENTIRE BODY WITHIN 24 HOURS- ITCHING. APPEARS AS CHICKEN POX.
This individual received the first dose of the Covid-19 Pfizer vaccine on 3/4/21 and a few days later passed away on 03/07/21.
down in bed for 24 hours aching; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "down in bed for 24 hours aching".  Additional information: The patient was fine to start with and then 2 days later her daughter was down in bed for 24 hours aching, patient was down in bed for 24 hours. That shot was given on a Wednesday and her patient did not go to work on Friday.  No follow-up attempts are possible. No further information is expected.
No additional AE reported; During the evaluation the customer reported that the PNEUMOVAX 23 was administered to the patient after the excursion occured.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided.  On 07-MAR-2022, the patient was vaccinated with improperly stored (product storage error) dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe (exact dose, strength, lot #, expiration date, site and route of administration were not provided) for prophylaxis. Temperature excursion information: temperature 1.5 degree Celsius, timeframe 24 hours. There was no previous temperature excursion. There was no additional adverse event reported.
1 day after receiving the COVID #2 vaccine, felt dizzy, body weakness, pain in stomach and head, fever (tactile), 1x vomit - food contents, blood pressure low (unable to recall).
Patient woke from her nap crankier than normal; within an hour, she was screaming inconsolably. Her legs became red and swollen at each vaccination site. She seemed to be running a slight fever, but nothing over 101F. At our pediatrician's advice, we gave her a dose of infant Tylenol, and applied cold compresses to the vaccination sites; this eased her discomfort. We needed to repeat the Tylenol at two more doses to keep her from becoming extremely upset at those times; irritability continued for about 36 hours after the vaccination.
No adverse effects reported; M-M-R II was a little brownish tint or rust orange in color; M-M-R II was a little brownish tint or rust orange in color; M-M-R II was a little brownish tint or rust orange in color; This spontaneous report was received from a pharmacist regarding a 59-year- old male patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.  On 03-MAY-2019 (reported as "yesterday"), the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (strength was not provided) (lot# R031616; expiry date: 01-NOV-2020) (lot #: R031636, expiry date not reported) for prophylaxis; and sterile diluent (MERCK STERILE DILUENT) (lot# S005087; expiry date: 30-SEP-2021).    The pharmacist reported that, on the date of vaccination, the vaccine was "a little brownish tint or rust orange in color" (product colour issue, poor quality product administered, and product quality issue). The pharmacist also reported the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II)  and sterile diluent (MERCK STERILE DILUENT) did not undergo a temperature excursion.  The outcome of product colour issue, poor quality product administered and product quality issue was not reported.    The reporter did not provide causality assessment between product colour issue, poor quality product administered and product quality issue and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II) and sterile diluent(MERCK STERILE DILUENT).  Lot number  R031616 is an invalid lot number for  Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(M-M-R II).
Multiple vaginal ulcers - acute reactive genital ulcers  Left deltoid swollen/red/warm to touch with multiple swollen grape sized lymph nodes in left axilla with edema spreading down to left breast for 72 hours after injection.
arm sore; couldn't move it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "arm sore"; LIMB DISCOMFORT (non-serious), outcome "recovered", described as "couldn't move it". Additional information: Reporter state that Has allergies like runny nose that  started  last Saturday. Due for 2nd dose the 20th, Also states her Mother and friend had the vaccine and their allergies were acting up. Her mom says her nose was stuffy. Her boyfriend had his arm sore and couldn't move it but was ok the next day.  No follow-up attempts are possible. No further information is expected.
04/14/2006 petechial rash 10d after MMR and varicella vaccine. Platelet Ct 104,000, 4/17/2006 Platelet count had increased to 176,000.
By night nausea started, had the runs, had high fever went on until 11am the next day. Had no energy/ strained her. Went to see the doctor, gave medicine for nausea and diarrhea. Symptoms went away and then restarted after 2 days. This pattern has continued since January. Has been ok for 8 days stomach wise but low grade fever persist.
Pain on right side of jaw; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and PAIN IN JAW (Pain on right side of jaw) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concomitant products included SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), METFORMIN and DULAGLUTIDE (TRULICITY) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 01-Apr-2021, the patient experienced PAIN IN JAW (Pain on right side of jaw). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea) and PAIN IN JAW (Pain on right side of jaw) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I experienced with post nasal drainage, resulted in a sore throat and fever. My symptoms were mild at first and that is when I called my doctor and was started on Paxlovid medication. I took at home test Binax COVID-19 test 10/19/2022 which was positive.  I have no symptoms today.
This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown age. On an unspecified date the patients were vaccinated with GARDASIL which was improperly stored at various temperatures. No other co-suspects were reported. No concomitant medications were reported. It was unknown if the patients had sought medical attention. No adverse reaction reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 64-year-old male patient received BNT162b2 (BNT162B2), in Feb2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 63 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Migraines" (unspecified if ongoing). No allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
Pt. complained of numbness and tingling in her injection arm. Assess BP 122/88, HR 71, O2 sat 97 %. No redness, swelling, or pain at injection site. Encouraged her to move arm around and to pump her fist to increase circulation. Observed patient for 45 mins. Numbness and tingling gradually improved, but still present in her hand especially her pinky and ring finger.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Shakiness-Medium, Additional Details: about 10 mins after administration patient stated they felt light headed, dizzy and chest tightness.  she requested we called the ambulance.
ZOSTAVAX administered 6/25/12. Pt had no complaints to provider. Pt called provider on 6/27/12 stating he has felt dizzy since time vaccine was given. Also having difficulty sleeping for which he took BENADRYL last night. Advised to see his primary provider for full evaluation of dizziness.
improperly stored; No additional adverse effects; This spontaneous report was received from a consumer and refers to a 2-month-old patient of unknown gender.     On an unknown date, temperature excursion and time frame were unknown. The previous temperature excursion was unknown. On an unknown date, the patient was only vaccinated with the first dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (dose, lot #, expiration date and anatomical location were not provided) orally for prophylaxis (product storage error). No additional adverse effects were reported (no adverse event).
Narrative:  Symptoms:  Headache, Myalgia, NauseaVomiting & body ache Treatment:
Sense of smell changed, onions, feces, bad breath, gasoline; all smell to me like antifreeze
Tingling headache that moved to the rest of my body, shortness of breath, blurry vision, and nausea
At the end of patient's monitoring after the covid-19 vaccine, patient said he felt like his heart rate was fast subjective feeling.  Medical provider and nurse assessed patient.  Patient had normal heart rate 60-64 rate, regular rate and rhythm on exam, normal sao2 94-95%,  elevated blood pressure 153/103,  174/92,  160/109,  153/93,  170/86.
Severe itching of my inside my eyes (upper and lower inside lids); bloodshot eyes; swelling of lids themselves. Felt like an allergy. Felt extremely itchy. Also had like a grittiness to my eyes. It was very severe. It lasted for two weeks before I was seen by the doctor. 1/25 -  Dr said my eyes were very inflamed. She rolled up my eyelids and said that I had bumps under my eyelids from severe inflammation. I had been using, at home, an OTC allergy eyedrop - Ketotisin Fumerate - that wasn't helping. Dr prescribed a steroid eye drop. They also gave me an Erythromycin ointment for outside of eyes because they said my skin was very dry and affected and she was trying to moisturize it. She described it as a toxic conjunctivitis. The steroid drops did help. I went back for a follow up and it was improved. Subsequent to that, I went back to doctor for an exam for eye glasses and she said there was still a residual of the bumpiness under the eye lids (March 17th).  Now I have been experiencing problems with that again that started a week ago today - April 12th. Having a more itchiness (extreme but not quite as severe as the first time) - redness; bloodshot eyes. I tried the OTC med again and it didn't help. I used the Steroid medication again twice and it did help it a bit...I am trying not to use the Steroid medication too much - so just trying to get the symptoms at bay with sparse use of Steroid drops.  (Received the 2nd dose - January 20, 2021.)
swelling of their gums and nasal passages; swelling of their gums; metallic taste in their mouth; esophageal reflux; burning in the throat; rash behind the ears and the upper neck; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (swelling of their gums and nasal passages), GINGIVAL SWELLING (swelling of their gums), DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux) and THROAT IRRITATION (burning in the throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 001A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (swelling of their gums and nasal passages), GINGIVAL SWELLING (swelling of their gums), DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux), THROAT IRRITATION (burning in the throat) and RASH (rash behind the ears and the upper neck). At the time of the report, NASAL CONGESTION (swelling of their gums and nasal passages) outcome was unknown and GINGIVAL SWELLING (swelling of their gums), DYSGEUSIA (metallic taste in their mouth), GASTROOESOPHAGEAL REFLUX DISEASE (esophageal reflux), THROAT IRRITATION (burning in the throat) and RASH (rash behind the ears and the upper neck) had resolved.            Concomitant medication was not provided. Treatment information was not provided.  It was reported that the symptoms have decreased since March but the nasal passages remain the worse and they were the last thing going away .   This case was linked to MOD-2021-404751 (Patient Link).
3/17-21:  fever & headache 3/27-30:  fever, pharyngitis with lymphadenopathy, Rx with Zpak 4/10-ongoing:erythematous mouth & pharynx (lost taste buds) and rash on face & extremities.  Rx with Zpak (no resolution) then Rx with Rocephin, no change; referred 4/30 to ENT (Kawasaki-like mouth) back to PCP 5/2
Patient called at 9 am on 5/3/2018 reporting he had shivering, shaking, fever and pain at 1 am after receiving the IMZ at 9.45 am on 5.2.2018. I  advised him that these were some of the reactions noted on the VIS. The reactions should subside in 2 to 3 days. I advised him to also contact his physician.
Severe headache, projectile vomiting, incoherent, unsteady gait,  stroke like symptoms, abdominal pain, bradycardia, decreased pulse ox, and severe pain.
patient received vaccine from a vial that was punctured for more than 12hs; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received vaccine from a vial that was punctured for more than 12hs) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 054C21A and 939676) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received vaccine from a vial that was punctured for more than 12hs). On 09-Jul-2021, EXPIRED PRODUCT ADMINISTERED (patient received vaccine from a vial that was punctured for more than 12hs) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.
No adverse events.  Patient called and set up an appointment for a flu shot with a technician.  After the vaccine was administered she presented a Covid Vaccine card.  She had intended to request a Moderna vaccine and had already received a flu shot earlier in the season.
Massive heart attack. Unusual and aggressive clot formation. Stent was place and almost immediately clotted again despite heparin infusions.
pt presents to ED with stroke like sx; positive for COVID; dexamethasone; ICU; pt experienced quickly evolving terminal sx; DNR/DNI; transitioned to Comfort Measures; under hospice care; pt expired in the hospital
Case number PHHY2011US68639 is an initial spontaneous report received from a nurse on 27 Jul 2011. This report refers to an adult female patient. She was sick for a year and her medical history included tonsillitis which occurred before the administration of RABAVERT vaccine. She was vaccinated with the first dose of pre exposure series of RABAVERT vaccine (batch number: 454100G) intramuscularly on 05 Jul 2011 and then received the day seven dose (batch number: 454100G) intramuscularly on 12 Jul 2011. After vaccination, she developed fever on 18 Jul 2011. She was reported to be septic and therefore, she was hospitalized. No event onset date for sepsis was reported. She had not yet received the third dose of RABAVERT vaccine. She was still in hospital and her condition remained unchanged. The nurse assessed this event as not related to the vaccine.
booster; Under her armpit she has some bloating/Swollen yes/Bloating under armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 57 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Dec2021 14:45 (Lot number: FJ1620) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01, Anatomical site of injection: Left Arm, Batch/Lot number: EP6955), administration date: 17Mar2021, when the patient was 57 years old, for Covid-19 immunization; Bnt162b2 (Dose: 02, Anatomical site of injection: Left Arm, Batch/Lot number: EP6955), administration date: 07Apr2021, when the patient was 57 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 08Dec2021 14:45, outcome "unknown", described as "booster"; SWELLING (non-serious) with onset Dec2021, outcome "unknown", described as "Under her armpit she has some bloating/Swollen yes/Bloating under armpit". Therapeutic measures were taken as a result of swelling.  Additional information: the patient takes Ibuprofen.  No follow-up attempts are possible. No further information is expected.
numbness in down arms and hands, numbness in legs and feet, migraines, period off track, can't see well need glasses, need  eyedrops due to dry eyes, anxiety,  short of breathe, can't sleep, tongue is numb, food does not taste rights, teeth are sensitive to everything it does not matter if it is hot cold or room temp, flu like symptoms  once a month for almost 10 days at a time,
Gravida 1 with last menstrual period of 12/05/2020.  Patient received 2nd dose of vaccine on 01/19/2021.  Patient had fever and body aches the next day 1/20/2021 and subsequently (3 weeks later)  was diagnosed with a miscarriage of pregnancy at 6 weeks 4 days, which exactly corresponds with the date of the vaccine and symptoms.